fbpx
[adzerk adTypes="3731"]
[adzerk adTypes="3773"]

  

In partnership with

& Monument Traders Alliance

Good day, 360! Here are some of our top movers today.

Plus → TODAY at 1pm EST Jeff Bishop sits down with former RagingBull student turned pro-trader, Nate Bear!  Join the power duo LIVE in Market Master’s – the hottest trading room around 🔥. Be the best prepared trader on the Street!

FOCUS LIST🔎

FGEN – Up over 50% in pre after announcing the Sale of FibroGen China to AstraZeneca for Approximately $160 Million

XOS – Up over 25% in pre after announcing major milestone: Xos Hub listed on Federal GSA Schedule

HLF – Up over 25% in pre after reporting better than expected earnings, appointing new CEO

In partnership with

Reasons you should be a Locked On NBA insider

What’s up, NBA fans! From our expert hosts who cover your team every day on our podcasts, we offer a free daily newsletter delivered right to your email so you don’t miss any of the action on the court. Get expert analysis, game previews, post-game breakdowns, trade talk, draft coverage, and more. We curate your daily ticket to everything NBA, giving you the rundown for each NBA team and the league news you need to know. Be one of thousands of fans who are already insiders – fast and easy.

HOTLIST🔥

FGEN – Up over 50% in pre after announcing the Sale of FibroGen China to AstraZeneca for Approximately $160 Million 

FibroGen Inc. (FGEN) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.

In the pre-market, the company announced the sale of its China subsidiary to AstraZeneca for approximately $160 million.

Highlights of the transaction  include:

Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently estimated to be approximately $75 million

Upon close, FibroGen will repay its term loan to Morgan Stanley Tactical Value, further simplifying the Company’s capital structure

Company’s cash runway extended into 2027

Company to continue to advance its oncology pipeline, with the initiation of the Phase 2 monotherapy trial of FG-3246 in metastatic castration-resistant prostate cancer (mCRPC) in 2Q 2025

Preliminary unaudited cash, cash equivalents, and accounts receivable of $121.1 million as of December 31, 2024

According to Finviz, based on yesterday’s close, FGEN’s market cap was approximately $56.63 million.

Shares of FGEN traded up over 50% in the pre-market in reaction to the sale.

The $0.88 area acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $0.97, $1 and then the pre-market high at $1.04. Beyond that, $1.20, $1.35, and $1.53 come into play.

Below $0.88, targets to the downside are $0.8410, $0.75, $0.65 and then a gap fill at $0.5620.

XOS – Up over 25% in pre after announcing major milestone: Xos Hub listed on Federal GSA Schedule

Xos Inc. (XOS) designs, manufactures, and sells battery-electric commercial vehicles.

In the after-hours, the company announcedthat its innovative Xos Hub™ has been officially added to the General Services Administration (GSA) Schedule. This milestone makes it easier than ever for federal agencies and authorized customers to quickly and efficiently procure the Xos Hub, a state-of-the-art mobile energy storage system and DC fast charger.

Dakota Semler, CEO and Co-Founder of Xos, Inc. stated:

“As Federal agencies seek to reduce operational expenses, the total cost of ownership benefits of EVs present a massive opportunity for budget savings.

Shares of XOS traded up over 25% in the pre-market in reaction to the news.

The $3.90 area acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $4.50, $4.90 and then the pre-market high at $5.60. Beyond that, $6.30, $7 and $7.50 come into play.

Below $3.90, targets to the downside are $3.76, $3.25 and then a gap fill at $3.13.

*together with Monument Traders Alliance

🎉The Ultimate Trading Party 🎉

On February 24th, Pro Trader Nate Bear will be opening up his private Daily Profits Live chatroom to celebrate his ONE HUNDREDTH 100% winner since starting the community March 2023!

For an entire week he’ll be demonstrating all the strategies he’s used to accomplish this massive trading feat.

HLF – Up over 25% in pre after reporting better than expected earnings, appointing new CEO 

Herbalife Ltd. (HLF) provides health and wellness products in North America and internationally offering products in the areas of weight management; targeted nutrition; energy and sports among others. 

In the after-hours yesterday, the company reportedfinancial results for the fourth quarter and year ended December 31, 2024.

Highlights include:

Net sales of $1.2 billion, down 0.6% vs. Q4 ’23 and at high end of guidance range

Includes 330 basis points of FX headwinds

Up 2.7% year-over-year on constant currency basis1

Net income of $177.9 million includes non-cash income tax benefits of $147.3 million; adjusted net income2 $36.8 million

Adjusted EBITDA2 of $150.0 million exceeds guidance; adjusted EBITDA2 margin up 340 basis points vs. Q4 ‘23

Diluted EPS of $1.74; adjusted diluted EPS2 $0.36

In addition, the Board of Directors have appointed Stephan Gratziani as Chief Executive Officer. 

Shares of HLF traded up over 25% in the pre-market in reaction to the news.

The first target for bulls is the pre-market high at $7.09. Beyond that $7.50, $8.20 and $9 come into play.

Below $7.09, targets to the downside are $6.60, $6.30, $5.90 and a gap fill at $5.62.

MARKET NEWS 📰

DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.

RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.

*Sponsored Content:If you purchase anything through a link in this email other than RagingBull (RB) services, you should assume that we have an affiliate relationship with the company providing the product that you purchase, and that we will be paid in some way. RB is not responsible for any content hosted on affiliate’s sites and it is the affiliate’s responsibility to ensure compliance with applicable laws. We recommend that you do your own independent research before purchasing anything. While we believe in the companies we form affiliate relationships with, please don’t spend any money on these products unless you believe they will help you achieve your goals.

WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.

 

[adzerk adTypes="2733"]
Author:

Leave your comment

Skip to content